Johnson & Johnson Chief Strategic Customer Officer Blasine Penkowski has been elected to serve as chair of the National Pharmaceutical Council (NPC) Board of Directors.
According to a press release, Penkowski will serve as chair for one year.
“Companies driving biopharmaceutical innovation face diverse challenges in today’s health care landscape,” NPC President and CEO Dan Leonard said in a statement. “Blasine offers rich experience and strategic insights that are critical in guiding NPC’s efforts to bring smart health policy research and analysis to these pressing discussions.”
To read the full press release, click here.
